Sumitomo Chemical India Ltd Q4 FY26 Results Analysis: EBITDA Margin Hits 20.72%, Debt-Free Balance Sheet

Sumitomo Chemical India Ltd's Q4 FY26 numbers came in mixed, with revenue of Rs. 683.74 Cr (+0.60% YoY) and PAT growth of +11.60% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Sumichem delivered on margin targets (20.72% EBITDA margin vs >20% target) but revenue growth was muted at +2.9% as pricing pressure offset volume gains. A debt-free balance sheet with Rs.1,221 Cr liquidity provides resilience, but working capital absorption and unresolved glyphosate regulation are near-term overhangs. The company's strong domestic and export volume growth suggests underlying demand is intact, with pricing stabilization being the key catalyst to watch.

Key Investment Insights

Key Positives

• Q4 FY26 revenue of Rs.6,837 Mn rebounded +20.4% QoQ after a weak Q3
• FY26 EBITDA margin of 20.72% exceeded management's >20% target
• PAT grew +11.6% YoY in Q4 FY26 to Rs.1,113 Mn
• Balance sheet is debt-free with Rs.1,221 Cr in cash and investments
• Trade receivables declined 6.1% YoY indicating improved collections
• Normalized FY26 PAT growth (adjusted for exceptional labour code charge) was +9.6% YoY

Risk Factors

• Revenue growth was just +2.9% for FY26 as pricing pressure (~17-18% realization decline) offset volume growth of 25%+
• Glyphosate regulatory overhang remains unresolved
• Capex of Rs.442 Mn was only 44% of the 15%-of-EBITDA target of Rs.1,006 Mn
• Net working capital absorbed Rs.71 Cr as inventories grew 8.9% and payables declined 18.8%